Answers are grounded in this paper and cite their sources.
Introduction: Without prophylactic colectomy, the lifetime colorectal cancer risk in familial adenomatous polyposis (FAP) patients approaches 100%. Even after surgery, adenomas frequently develop in the residual intestinal mucosa, underscoring the need for effective chemopreventive agents. Here, we evaluated the chemopreventive effect of lithium on adenoma initiation. Methods: This single-arm, phase II trial enrolled FAP patients aged 18-35 years without history of colectomy. In an 18-month protocol, participants received daily lithium carbonate for 6-12 months. Colonoscopies with biopsies of normal mucosa were conducted at baseline, 6, 12 and 18 months. The primary endpoint was the number of APC -deficient pre-malignant clones over time, assessed by tracing mutant clones via marker gene expression. Secondary endpoints included adenoma burden, safety and tolerability. Investigators were blinded during analyses. Results: In total, 12 FAP patients underwent baseline colonoscopy, the full analysis set included 11 patients who received at least one study dose. Across all participants, no significant change in clone frequency was observed (χ 2 = 5.09, df = 3, p =0.165). Moreover, no significant effect on adenoma burden was detected. Lithium was well tolerated, with only grade 1-2 adverse events, mostly gastrointestinal (nausea and diarrhoea: n=3, 27.27%). Conclusion: This is the first trial to trace and inhibit mutant clone expansion as efficacy endpoint by boosting normal tissue fitness, aimed at preventing adenoma formation. Although lithium had no effect on the expansion APC -deficient pre-malignant clones or adenoma burden after six months, aberrant clones were detected in histologically normal mucosa, demonstrating the feasibility of tracing early tumorigenesis in humans. Trial registration: ClinicalTrials.gov (NCT05402891).
No takes yet. Share an insight, caveat, or question.
Linssen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: